The effect of prophylaxis on the outcome of HIV-associated Pneumocystis carinii pneumonia.
Ewig
S
S
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D010419:Pentamidine / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D016896:Treatment Outcome
D000935:Antifungal Agents; D010419:Pentamidine